Neurocrine Biosciences Market Sentiment

Neurocrine Biosciences Inc

NBIXNASDAQ

Trade with Public

$140.71

-1.13-0.8%

Últ. Act.: Oct 1, 4:28 PM

$140.71

-1.13-0.8%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Neurocrine Biosciences Market Sentiment

Market sentiment signals for Neurocrine Biosciences (NBIX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 6.4% short float

Options Flow▲ 0.46 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

26 analysts

Options Flow (P/C)

0.46

More calls — Bullish

59 calls · 27 puts

Avg Consensus PT

$200

+42.1%

Highest Price Target

$253

+79.8%

Citigroup

Lowest Price Target

$160

+13.7%

Wolfe Research

Short Interest

6.4%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	UBS	Ashwani Verma—	+52.1%	$231 → $214	Maintained	Buy
Sep 11, 2026	Morgan Stanley	Jeffrey Hung—	+30.1%	$182 → $183	Maintained	Equal-Weight
Sep 8, 2026	RBC Capital	Brian Abrahams—	+40.7%	$198 → $198	Maintained	Outperform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+79.8%	$249 → $253	Maintained	Buy
Aug 13, 2026	Morgan Stanley	Jeffrey Hung—	+29.3%	$196 → $182	Maintained	Equal-Weight
Aug 3, 2026	Canaccord Genuity	Sumant Kulkarni—	+49.2%	$200 → $210	Maintained	Buy
Aug 3, 2026	Truist Securities	Danielle Brill—	+51.4%	$200 → $213	Maintained	Buy
Aug 3, 2026	Wedbush	Laura Chico—	+37.9%	$185 → $194	Maintained	Outperform
Jul 31, 2026	Citigroup	Yigal Nochomovitz—	+77.0%	$246 → $249	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	+40.7%	$195 → $198	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Jeffrey Hung—	+39.3%	$193 → $196	Maintained	Equal-Weight
Jul 31, 2026	TD Cowen	Phil Nadeau—	+56.3%	$200 → $220	Maintained	Buy
Jul 31, 2026	Piper Sandler	David Amsellem—	+49.2%	$207 → $210	Maintained	Overweight
Jul 31, 2026	Cantor Fitzgerald	Josh Schimmer—	+52.8%	$210 → $215	Maintained	Overweight
Jul 31, 2026	Guggenheim	Yatin Suneja—	+57.8%	$200 → $222	Maintained	Buy
Jul 31, 2026	Stifel	Paul Matteis—	+52.8%	$188 → $215	Maintained	Buy
Jul 31, 2026	Needham	Ami Fadia—	+45.0%	$200 → $204	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+42.1%	$175 → $200	Maintained	Buy
Jul 17, 2026	Wells Fargo	Mohit Bansal—	+42.1%	$175 → $200	Maintained	Overweight
Jul 13, 2026	Truist Securities	Danielle Brill—	+42.1%	$155 → $200	Maintained	Buy
Jul 13, 2026	BMO Capital	Evan Seigerman—	+20.8%	$144 → $170	Maintained	Market Perform
Jul 7, 2026	RBC Capital	Brian Abrahams—	+38.6%	$183 → $195	Maintained	Outperform
Jun 30, 2026	UBS	Ashwani Verma—	+47.8%	$182 → $208	Maintained	Buy
Jun 2, 2026	Goldman Sachs	Corinne Johnson—	+51.4%	$213	Reinstates	Buy
May 29, 2026	RBC Capital	Brian Abrahams—	+30.1%	$180 → $183	Maintained	Outperform